Advanced Search
Interpretation of soft tissue sarcoma (retroperitoneal sarcoma) section in NCCN clinical practice guideline[J]. Chin J Clin Med, 2019, 26(3): 321-325. DOI: 10.12025/j.issn.1008-6358.2019.20190576
Citation: Interpretation of soft tissue sarcoma (retroperitoneal sarcoma) section in NCCN clinical practice guideline[J]. Chin J Clin Med, 2019, 26(3): 321-325. DOI: 10.12025/j.issn.1008-6358.2019.20190576

Interpretation of soft tissue sarcoma (retroperitoneal sarcoma) section in NCCN clinical practice guideline

More Information
  • Received Date: April 19, 2019
  • Revised Date: May 06, 2019
  • Soft tissue sarcoma is a rare malignant tumor originated from soft tissue. National Comprehensive Cancer Network (NCCN) has continually updated clinical practice guideline in soft tissue sarcoma. This article reviews the retroperitoneal soft tissue sarcoma section in the guideline, mainly involving the application of multi-discipline team (MDT) in the retroperitoneal sarcoma (RPS) treatment process, grading and staging, biopsy principles, surgical principles, radiotherapy principles, and other contents.
  • [1]
    Lawrence W Jr, Donegan WL, Natarajan N, et al. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg, 1987, 205(4): 349-359.
    [2]
    Raut CP, Pisters PW. Retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol, 2006, 94(1): 81-87.
    [3]
    Clasby R, Tilling K, Smith MA, Fletcher CD. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg. 1997 Dec;84(12):1692-6.
    [4]
    中国抗癌协会肉瘤专业委员会,中国临床肿瘤学会.软组织肉瘤诊治中国专家共识(2015年版)[J].中华肿瘤杂志,2016,38(4):310-320.
    [5]
    Domanski HA. Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges. Diagn Cytopathol. 2007 Dec;35(12):768-73.
    [6]
    Van Houdt WJ, Schrijver AM, Cohen-Hallaleh RB, et al. Needle tract seeding following core biopsies in retroperitoneal sarcoma. Eur J Surg Oncol 2017;43:1740-5.
    [7]
    Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009 Nov;10(11):1045-52.
    [8]
    Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol. 2008 Dec 15;98(8):607-10.
    [9]
    Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, Laplanche A. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009 Jan 1;27(1):31-7.
    [10]
    Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, Lozza L, Pennacchioli E, Mariani L, Casali PG. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009 Jan 1;27(1):24-30.
    [11]
    Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998 Sep;228(3):355-65.
    [12]
    Gronchi A, Pollock R. Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America. Ann Surg Oncol. 2011Aug;18(8):2107-10
    [13]
    Gronchi A, Casali PG, Fiore M, Mariani L, Lo Vullo S, Bertulli R, Colecchia M, Lozza L, Olmi P, Santinami M, Rosai J. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004 Jun 1;100(11):2448-55.
    [14]
    Bagaria SP, Neville M, Gray RJ, Gabriel E, Ashman JB, Attia S, Wasif N. The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions. Sarcoma. 2018 Jul 24;2018:3056562.
    [15]
    Zlotecki RA, Katz TS, Morris CG, Lind DS, Hochwald SN. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol. 2005 Jun;28(3):310-6
    [16]
    Stucky CC, Wasif N, Ashman JB, Pockaj BA, Gunderson LL, Gray RJ. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma. J Surg Oncol. 2014 Jun;109(8):798-803.
    [17]
    Yoon SS, Chen YL, Kambadakone A, Schmidt B, DeLaney TF. Surgical placement of biologic mesh spacers prior to external beam radiation for retroperitoneal and pelvic tumors. Pract Radiat Oncol. 2013 Jul-Sep;3(3):199-208.根据手术根治程度的不同,术后治疗和随访也有所不同。无特殊局部复发风险的R0切除无需术后常规放疗。接受过术前放疗的R1切除患者经过MDT讨论后可以考虑术后放疗。

Catalog

    Article views (2044) PDF downloads (885) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return